Athersys Inc (NASDAQ:ATHX)

Data as of 3:59pm ET
 +0.08 / +5.88%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Athersys, Inc. operates as a biopharmaceutical company, which is engaged in the discovery and development of therapies designed to extend and enhance the quality of human life. It establishes product development programs through the application of proprietary technologies in the field of regenerative medicine. The company's product development program, MultiStem, a proprietary off the shelf stem cell product used to treat indications in the inflammatory & immune, neurological and cardiovascular disease areas. Athersys was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Contact Information

Athersys, Inc.
3201 Carnegie Avenue
Cleveland Ohio 44115-2634
P:(216) 431-9900
Investor Relations:



Other institutional8.31%
Individual stakeholders7.78%
Mutual fund holders7.03%

Top Executives

Gil van BokkelenChairman & Chief Executive Officer
William B. J. LehmannPresident, Chief Operating Officer & Secretary
Laura K. CampbellVice President-Finance
John J. HarringtonDirector, Chief Scientific Officer & Executive VP
Manal MorsyVice President & Head-Global Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.